Gofen & Glossberg LLC IL lowered its stake in shares of CVS Health Corp (NYSE:CVS) by 26.4% during the fourth quarter, HoldingsChannel reports. The firm owned 36,288 shares of the pharmacy operator’s stock after selling 13,000 shares during the period. Gofen & Glossberg LLC IL’s holdings in CVS Health were worth $2,631,000 as of its most recent SEC filing.
A number of other hedge funds also recently added to or reduced their stakes in the business. FMR LLC increased its holdings in shares of CVS Health by 22.0% in the 2nd quarter. FMR LLC now owns 30,150,634 shares of the pharmacy operator’s stock valued at $2,425,920,000 after acquiring an additional 5,446,930 shares during the period. Truepoint Inc. increased its holdings in shares of CVS Health by 8,578.9% in the 3rd quarter. Truepoint Inc. now owns 3,757,530 shares of the pharmacy operator’s stock valued at $3,758,000 after acquiring an additional 3,714,235 shares during the period. Ameriprise Financial Inc. increased its holdings in shares of CVS Health by 30.2% in the 3rd quarter. Ameriprise Financial Inc. now owns 7,977,370 shares of the pharmacy operator’s stock valued at $648,683,000 after acquiring an additional 1,849,593 shares during the period. Parametric Portfolio Associates LLC increased its holdings in shares of CVS Health by 71.5% in the 2nd quarter. Parametric Portfolio Associates LLC now owns 3,949,854 shares of the pharmacy operator’s stock valued at $317,805,000 after acquiring an additional 1,647,168 shares during the period. Finally, Stifel Financial Corp increased its holdings in shares of CVS Health by 5,248.2% in the 3rd quarter. Stifel Financial Corp now owns 1,299,244 shares of the pharmacy operator’s stock valued at $105,622,000 after acquiring an additional 1,274,951 shares during the period. 83.23% of the stock is currently owned by institutional investors.
A number of equities analysts have recently commented on CVS shares. Robert W. Baird reaffirmed a “hold” rating and issued a $77.00 target price on shares of CVS Health in a report on Friday, October 27th. Needham & Company LLC raised shares of CVS Health from a “hold” rating to a “buy” rating and lifted their target price for the company from $69.02 to $79.00 in a report on Friday, November 10th. Deutsche Bank reaffirmed a “hold” rating on shares of CVS Health in a report on Tuesday, December 5th. Mizuho set a $90.00 target price on shares of CVS Health and gave the company a “buy” rating in a report on Tuesday, October 24th. Finally, Raymond James Financial reaffirmed a “buy” rating on shares of CVS Health in a report on Monday, December 4th. Two equities research analysts have rated the stock with a sell rating, seven have issued a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the stock. CVS Health presently has an average rating of “Buy” and an average target price of $87.82.
CVS Health Corp (CVS) opened at $70.66 on Wednesday. CVS Health Corp has a 1 year low of $66.45 and a 1 year high of $84.00. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.02 and a quick ratio of 0.52. The firm has a market cap of $72,944.85, a price-to-earnings ratio of 10.92, a P/E/G ratio of 1.22 and a beta of 0.93.
CVS Health (NYSE:CVS) last issued its earnings results on Thursday, February 8th. The pharmacy operator reported $1.92 EPS for the quarter, topping the consensus estimate of $1.88 by $0.04. The company had revenue of $48.39 billion for the quarter, compared to analyst estimates of $47.54 billion. CVS Health had a net margin of 3.58% and a return on equity of 17.21%. The business’s revenue was up 5.3% on a year-over-year basis. During the same period in the previous year, the firm earned $1.71 EPS. equities analysts anticipate that CVS Health Corp will post 6.38 earnings per share for the current year.
The business also recently announced a quarterly dividend, which was paid on Friday, February 2nd. Shareholders of record on Wednesday, January 24th were given a dividend of $0.50 per share. The ex-dividend date of this dividend was Tuesday, January 23rd. This represents a $2.00 annualized dividend and a dividend yield of 2.83%. CVS Health’s payout ratio is currently 30.91%.
About CVS Health
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corp (NYSE:CVS).
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.